Encouragingly, MAPK3 and CD44, as hub genes, were not only enriched in “ferroptosis” and “acute myeloid leukemia” pathways but also significantly correlated with prognosis and immune cell infiltration in AML patients. Here, CD44 is linked to acute myeloid leukemia.